Jewish Hospital Lights Up Building Blue for Colon Cancer Awareness Month in March
Louisville, KY—Jewish Hospital and Jewish Cancer Care, a part of KentuckyOne Health, will be lighting up the Rudd Heart & Lung Building blue during the month of March to bring awareness to colon cancer, the third most commonly diagnosed cancer and second leading cause of cancer death in men and women.
The building at 201 Abraham Flexner Way in downtown Louisville will begin shining blue the evening of Thursday, March 1, 2012.
Kentucky has the highest colon cancer rate in the nation and is among the top five states for colon cancer deaths annually.
“Colon cancer is a deadly disease that is 90 percent preventable through early detection,” said Mark Milburn, vice president Jewish Cancer Care. “Regular screenings are the best way to diagnose the cancer early or even prevent it altogether.”
Colon cancer can be diagnosed through regular screening, such as a colonoscopy, a painless outpatient procedure that is covered by most health insurance providers.
Awareness is an important tool for colon cancer prevention because colon cancer can exist without symptoms or warning signs. In addition, hereditary factors that increase an individuals risk for colon cancer can be passed down from generation to generation, so it’s important for anyone with a family history to have a colon cancer screening.
Jewish Cancer Care’s goal is to provide our patients the most advanced cancer care available. This program is available at seven area hospital/outpatient care locations that provide patients convenient diagnostic services as well as facilities focused on the treatment of cancer including infusion therapy and radiation therapy.
The program is accredited through the American College of Surgeons Commission on Cancer Accredited Program.
Jewish Hospital will also provide facts about colon cancer via Facebook and Twitter throughout the month of March. Visit us at: Facebook.com/jewishhospital or Twitter.com/jewishhospital.
About Jewish Hospital
Jewish Hospital, a part of KentuckyOne Health, is an internationally renowned high-tech tertiary referral center developing leading-edge advancements in hand and microsurgery, heart and lung care, home care, rehab medicine (including sports medicine), orthopaedics, neuroscience, occupational health, organ transplantation and outpatient and primary care. Site of the world’s first successful hand transplant, the world’s first and second successful AbioCor® Implantable Replacement Heart procedures, and world’s first trial of cardiac stem cells in chronic heart failure, the hospital is in the select group that performs heart, lung, liver, kidney and pancreas transplantation.